131 related articles for article (PubMed ID: 6983870)
1. Immunological follow-up of non-Hodgkin's lymphoma (NHL) in children.
Bogusławska-Jaworska J; Chybicka A; Pisarek J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):733-8. PubMed ID: 6983870
[TBL] [Abstract][Full Text] [Related]
2. Immunologic status of children with Hodgkin's disease (HD).
Bogusławska-Jaworska J; Chybicka A; Pisarek J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):725-31. PubMed ID: 6983869
[TBL] [Abstract][Full Text] [Related]
3. Immune and phagocytic function in patients on maintenance dialysis and post-transplantation.
Hosking CS; Atkins RC; Scott DF; Holdsworth SR; Fitzgerald MG; Shelton MJ
Clin Nephrol; 1976 Dec; 6(6):501-5. PubMed ID: 795582
[TBL] [Abstract][Full Text] [Related]
4. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
5. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
Bogusławska-Jaworska J; Chybicka A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
7. [Various parameters of humoral and cellular immunity in children with iron deficiency].
Guzikowska E; Cholewa Z; Bujniewicź E; Moskała H; Guzikowski K; Madeyski J
Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):718-9. PubMed ID: 2641796
[TBL] [Abstract][Full Text] [Related]
8. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
Rao SS; Rao TD; Rao PR
Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
[TBL] [Abstract][Full Text] [Related]
9. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M
Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045
[TBL] [Abstract][Full Text] [Related]
10. Reduced natural killer cell activity in non-hodgkin's lymphoma.
Neri A; Brugiatelli M; Ozger Topuz U; Astaldi G
Boll Ist Sieroter Milan; 1981 Nov; 60(5):394-407. PubMed ID: 7041921
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
[TBL] [Abstract][Full Text] [Related]
12. [Immunological aspects of pulmonary sarcoidosis].
Baian A; Blanarikova Z
Probl Tuberk; 1991; (5):42-3. PubMed ID: 1924242
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].
Schnabel I; Fricke HJ; Jansa U; Lehmann G
Z Gesamte Inn Med; 1979 Dec; 34(23):704-8. PubMed ID: 317767
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.
Opat P; Kolár V; Lauerová L; Pintera J; Zemanová D
Neoplasma; 1980; 27(3):301-6. PubMed ID: 7453850
[TBL] [Abstract][Full Text] [Related]
15. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
16. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
Pituch-Noworolska A; Miezyński W
Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
[TBL] [Abstract][Full Text] [Related]
17. [Immunity in hypothyroid children (author's transl)].
Borrajo E; Alpera R; Donat J; Escribano A; Colomer C; Plasencia A; López MJ
An Esp Pediatr; 1982 May; 16(5):369-76. PubMed ID: 6981366
[TBL] [Abstract][Full Text] [Related]
18. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
19. [T and B lymphocytes in the ontogenetic development of man].
Smogorzewska E; Kunicka A; Siwińska-Gołebiowska H; Chazan B
Probl Med Wieku Rozwoj; 1981; 10():21-9. PubMed ID: 6984186
[TBL] [Abstract][Full Text] [Related]
20. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
